Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

A Novel Model of Chronic Kidney Disease in Rats: Dietary Adenine in Combination with Unilateral Nephrectomy.

Muñoz Abellán C, Mangold-Gehring S, Micus S, Beddies G, Moritz A, Hartmann E, Lehmann W, Eitner F.

Kidney Dis (Basel). 2019 Jun;5(3):135-143. doi: 10.1159/000495750. Epub 2019 Jan 16.

2.

Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.

van Roeyen CRC, Martin IV, Drescher A, Schuett KA, Hermert D, Raffetseder U, Otten S, Buhl EM, Braun GS, Kuppe C, Liehn E, Boor P, Weiskirchen R, Eriksson U, Gross O, Eitner F, Floege J, Ostendorf T.

Kidney Int. 2019 May;95(5):1103-1119. doi: 10.1016/j.kint.2018.11.031. Epub 2019 Feb 28.

PMID:
30827511
3.

Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).

Schimpf JI, Klein T, Fitzner C, Eitner F, Porubsky S, Hilgers RD, Floege J, Groene HJ, Rauen T.

BMC Nephrol. 2018 Nov 19;19(1):328. doi: 10.1186/s12882-018-1128-6.

4.

Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.

Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.

Kidney Blood Press Res. 2018;43(5):1563-1572. doi: 10.1159/000494442. Epub 2018 Oct 22.

5.

The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective.

Krishnan SM, Kraehling JR, Eitner F, Bénardeau A, Sandner P.

Int J Mol Sci. 2018 Jun 9;19(6). pii: E1712. doi: 10.3390/ijms19061712. Review.

6.

Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.

Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.

J Am Soc Nephrol. 2018 Jan;29(1):317-325. doi: 10.1681/ASN.2017060713. Epub 2017 Oct 17.

7.

GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.

Kiryluk K, Li Y, Moldoveanu Z, Suzuki H, Reily C, Hou P, Xie J, Mladkova N, Prakash S, Fischman C, Shapiro S, LeDesma RA, Bradbury D, Ionita-Laza I, Eitner F, Rauen T, Maillard N, Berthoux F, Floege J, Chen N, Zhang H, Scolari F, Wyatt RJ, Julian BA, Gharavi AG, Novak J.

PLoS Genet. 2017 Feb 10;13(2):e1006609. doi: 10.1371/journal.pgen.1006609. eCollection 2017 Feb.

8.

Opponent's comments.

Rauen T, Eitner F, Fitzner C, Floege J.

Nephrol Dial Transplant. 2016 Nov;31(11):1770. No abstract available.

PMID:
27807127
9.

Con: STOP immunosuppression in IgA nephropathy.

Rauen T, Eitner F, Fitzner C, Floege J.

Nephrol Dial Transplant. 2016 Nov;31(11):1771-1774. Epub 2016 Aug 11.

PMID:
27515693
10.

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Floege J, Rauen T, Eitner F.

N Engl J Med. 2016 Mar 10;374(10):992-3. doi: 10.1056/NEJMc1600141. No abstract available.

PMID:
26962736
11.

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J; STOP-IgAN Investigators.

N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463.

12.

Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis.

Boor P, Bábíčková J, Steegh F, Hautvast P, Martin IV, Djudjaj S, Nakagawa T, Ehling J, Gremse F, Bücher E, Eriksson U, van Roeyen CR, Eitner F, Lammers T, Floege J, Peutz-Kootstra CJ, Ostendorf T.

Am J Pathol. 2015 Aug;185(8):2132-42. doi: 10.1016/j.ajpath.2015.04.022.

PMID:
26216283
13.

Nonsteroidal antagonists of the mineralocorticoid receptor.

Kolkhof P, Nowack C, Eitner F.

Curr Opin Nephrol Hypertens. 2015 Sep;24(5):417-24. doi: 10.1097/MNH.0000000000000147. Review.

PMID:
26083526
14.

Increased cerebral water content in hemodialysis patients.

Reetz K, Abbas Z, Costa AS, Gras V, Tiffin-Richards F, Mirzazade S, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Eitner F, Gross T, Schulz JB, Floege J, Shah NJ.

PLoS One. 2015 Mar 31;10(3):e0122188. doi: 10.1371/journal.pone.0122188. eCollection 2015.

15.

The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.

Tiffin-Richards FE, Costa AS, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Kuckuck K, Gross T, Eitner F, Floege J, Schulz JB, Reetz K.

PLoS One. 2014 Oct 27;9(10):e106700. doi: 10.1371/journal.pone.0106700. eCollection 2014.

16.

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerová D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Pączek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG.

Nat Genet. 2014 Nov;46(11):1187-96. doi: 10.1038/ng.3118. Epub 2014 Oct 12.

17.

Usefulness of bioimpedance spectroscopy for detection of hypotensive episode during dialysis.

Ismail AH, Trué N, Gross T, Eilebrecht B, Walter M, Schlieper G, Eitner F, Floege J, Leonhardt S.

ASAIO J. 2014 Sep-Oct;60(5):570-5. doi: 10.1097/MAT.0000000000000104.

PMID:
24830800
18.

Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis.

Costa AS, Tiffin-Richards FE, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Eitner F, Gross T, Shah NJ, Schulz JB, Floege J, Reetz K.

Am J Kidney Dis. 2014 Sep;64(3):434-42. doi: 10.1053/j.ajkd.2014.02.012. Epub 2014 Mar 27.

PMID:
24679895
19.

Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury.

Kolkhof P, Delbeck M, Kretschmer A, Steinke W, Hartmann E, Bärfacker L, Eitner F, Albrecht-Küpper B, Schäfer S.

J Cardiovasc Pharmacol. 2014 Jul;64(1):69-78. doi: 10.1097/FJC.0000000000000091.

PMID:
24621652
20.

Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database.

Naik MG, Heller KM, Arns W, Budde K, Diekmann F, Eitner F, Fischereder M, Goßmann J, Heyne N, Morath C, Riester U, Gwinner W, Jürgensen JS; German Sirolimus Study Group.

Clin Transplant. 2014 Jan;28(1):67-79. doi: 10.1111/ctr.12280. Epub 2013 Dec 26.

PMID:
24372584
21.

Pilot study of non-contrast-enhanced MRI vs. ultrasound in renal transplant recipients with acquired cystic kidney disease: a prospective intra-individual comparison.

Mühlfeld AS, Lange C, Kroll G, Floege J, Krombach GA, Kuhl C, Eitner F, Schrading S.

Clin Transplant. 2013 Nov-Dec;27(6):E694-701. doi: 10.1111/ctr.12253. Epub 2013 Oct 1.

PMID:
24118352
22.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

23.

Long-term sustainability of hand hygiene improvements in the hemodialysis setting.

Scheithauer S, Eitner F, Häfner H, Floege J, Lemmen SW.

Infection. 2013 Jun;41(3):675-80. doi: 10.1007/s15010-013-0424-0. Epub 2013 Feb 23.

PMID:
23435688
24.

Growth arrest-specific protein 1 is a novel endogenous inhibitor of glomerular cell activation and proliferation.

van Roeyen CR, Zok S, Pruessmeyer J, Boor P, Nagayama Y, Fleckenstein S, Cohen CD, Eitner F, Gröne HJ, Ostendorf T, Ludwig A, Floege J.

Kidney Int. 2013 Feb;83(2):251-63. doi: 10.1038/ki.2012.400. Epub 2012 Dec 19.

25.

Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts.

Seikrit C, Henkel C, van Roeyen CR, Bokemeyer D, Eitner F, Martin IV, Boor P, Knüchel R, Meyer HE, Müller-Newen G, Eriksson U, Floege J, Ostendorf T.

Nephrol Dial Transplant. 2013 Apr;28(4):889-900. doi: 10.1093/ndt/gfs509. Epub 2012 Dec 9.

PMID:
23229927
26.

Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.

Villa L, Boor P, Konieczny A, Kunter U, van Roeyen CR, Denecke B, Gan L, Neusser MA, Cohen CD; ERCB Consortium;, Eitner F, Scholl T, Ostendorf T, Floege J.

J Pathol. 2013 Apr;229(5):672-84. doi: 10.1002/path.4151. Epub 2013 Mar 5.

PMID:
23192593
27.

Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis.

Martin IV, Borkham-Kamphorst E, Zok S, van Roeyen CR, Eriksson U, Boor P, Hittatiya K, Fischer HP, Wasmuth HE, Weiskirchen R, Eitner F, Floege J, Ostendorf T.

Am J Pathol. 2013 Jan;182(1):107-17. doi: 10.1016/j.ajpath.2012.09.006. Epub 2012 Nov 7.

PMID:
23141925
28.

In search of a better understanding of IgA nephropathy-associated hematuria.

Eitner F, Floege J.

Kidney Int. 2012 Sep;82(5):513-5. doi: 10.1038/ki.2012.160.

29.

Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting.

Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, Eitner F, Reich A, Schulz JB, Nasreddine ZS, Reetz K.

Dement Geriatr Cogn Disord. 2012;33(6):379-84. doi: 10.1159/000340006. Epub 2012 Jul 11.

30.

Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.

Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J, Wyatt RJ, Mucha K, Perola M, Kristiansson K, Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A, Metzger M, Thibaudin L, Wanner C, Jager KJ, Goto S, Maixnerova D, Karnib HH, Nagy J, Panzer U, Xie J, Chen N, Tesar V, Narita I, Berthoux F, Floege J, Stengel B, Zhang H, Lifton RP, Gharavi AG.

PLoS Genet. 2012;8(6):e1002765. doi: 10.1371/journal.pgen.1002765. Epub 2012 Jun 21.

31.

[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations].

Arns W, Budde K, Eitner F, Gwinner W, Hugo C, Pressmar K, Weimann A, Witzke O.

Dtsch Med Wochenschr. 2011 Dec;136(49):2554-9. doi: 10.1055/s-0031-1292822. Epub 2011 Nov 30. German. No abstract available.

PMID:
22131077
32.

Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N; ALMS Group.

N Engl J Med. 2011 Nov 17;365(20):1886-95. doi: 10.1056/NEJMoa1014460.

33.

Current therapy for IgA nephropathy.

Floege J, Eitner F.

J Am Soc Nephrol. 2011 Oct;22(10):1785-94. doi: 10.1681/ASN.2011030221. Epub 2011 Sep 8. Review.

34.

Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D.

van Roeyen CR, Eitner F, Boor P, Moeller MJ, Raffetseder U, Hanssen L, Bücher E, Villa L, Banas MC, Hudkins KL, Alpers CE, Ostendorf T, Floege J.

Kidney Int. 2011 Dec;80(12):1292-305. doi: 10.1038/ki.2011.278. Epub 2011 Aug 24.

35.

The German Chronic Kidney Disease (GCKD) study: design and methods.

Eckardt KU, Bärthlein B, Baid-Agrawal S, Beck A, Busch M, Eitner F, Ekici AB, Floege J, Gefeller O, Haller H, Hilge R, Hilgers KF, Kielstein JT, Krane V, Köttgen A, Kronenberg F, Oefner P, Prokosch HU, Reis A, Schmid M, Schaeffner E, Schultheiss UT, Seuchter SA, Sitter T, Sommerer C, Walz G, Wanner C, Wolf G, Zeier M, Titze S.

Nephrol Dial Transplant. 2012 Apr;27(4):1454-60. doi: 10.1093/ndt/gfr456. Epub 2011 Aug 22.

PMID:
21862458
36.

Improving hand hygiene compliance rates in the haemodialysis setting: more than just more hand rubs.

Scheithauer S, Eitner F, Mankartz J, Haefner H, Nowicki K, Floege J, Lemmen SW.

Nephrol Dial Transplant. 2012 Feb;27(2):766-70. doi: 10.1093/ndt/gfr365. Epub 2011 Jul 12.

PMID:
21750162
37.

Steroid-related osteonecrosis--an update.

Drescher W, Schlieper G, Floege J, Eitner F.

Nephrol Dial Transplant. 2011 Sep;26(9):2728-31. doi: 10.1093/ndt/gfr212. Epub 2011 May 19. No abstract available.

PMID:
21602181
38.

The PDGF family in renal fibrosis.

Ostendorf T, Eitner F, Floege J.

Pediatr Nephrol. 2012 Jul;27(7):1041-50. doi: 10.1007/s00467-011-1892-z. Epub 2011 May 21. Review.

PMID:
21597969
39.

Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.

Villa L, Boor P, Konieczny A, Kunter U, van Roeyen CR, Denecke B, Gan L, Kupper MB, Hoffmann K, Eitner F, Ostendorf T, Floege J.

Nephrol Dial Transplant. 2011 Oct;26(10):3131-43. doi: 10.1093/ndt/gfr096. Epub 2011 Mar 17.

PMID:
21414972
40.

[Incidental finding: elevated serum creatinine].

Floege J, Eitner F.

MMW Fortschr Med. 2010 Sep 16;152(37):32-3. German. No abstract available.

PMID:
21192450
41.

Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients.

Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU, Fiedler R, Guba M, Hilgers RD, Floege J, Fischereder M.

Nephrol Dial Transplant. 2011 Jun;26(6):2013-7. doi: 10.1093/ndt/gfq689. Epub 2010 Nov 11.

PMID:
21071545
42.

Combined immunosuppression in high-risk patients with IgA nephropathy?

Floege J, Eitner F.

J Am Soc Nephrol. 2010 Oct;21(10):1604-6. doi: 10.1681/ASN.2010080839. Epub 2010 Sep 9. No abstract available.

43.

Differential activation of memory-relevant brain regions during a dialysis cycle.

Lux S, Mirzazade S, Kuzmanovic B, Plewan T, Eickhoff SB, Shah NJ, Floege J, Fink GR, Eitner F.

Kidney Int. 2010 Oct;78(8):794-802. doi: 10.1038/ki.2010.253. Epub 2010 Jul 28.

44.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

45.

PDGF-C mediates glomerular capillary repair.

Boor P, van Roeyen CR, Kunter U, Villa L, Bücher E, Hohenstein B, Hugo CP, Eriksson U, Satchell SC, Mathieson PW, Eitner F, Floege J, Ostendorf T.

Am J Pathol. 2010 Jul;177(1):58-69. doi: 10.2353/ajpath.2010.091008. Epub 2010 May 20.

46.

Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy?

Eitner F, Floege J.

Nat Rev Nephrol. 2010 May;6(5):252-4. doi: 10.1038/nrneph.2010.31. No abstract available.

PMID:
20424626
47.

Model-based correction of the influence of body position on continuous segmental and hand-to-foot bioimpedance measurements.

Medrano G, Eitner F, Walter M, Leonhardt S.

Med Biol Eng Comput. 2010 Jun;48(6):531-41. doi: 10.1007/s11517-010-0602-5. Epub 2010 Apr 20.

PMID:
20405231
48.

A novel bioimpedance technique to monitor fluid volume state during hemodialysis treatment.

Medrano G, Eitner F, Floege J, Leonhardt S.

ASAIO J. 2010 May-Jun;56(3):215-20. doi: 10.1097/MAT.0b013e3181d89160.

PMID:
20404719
49.

Analysis of calcifications in patients with coral reef aorta.

Schlieper G, Grotemeyer D, Aretz A, Schurgers LJ, Krüger T, Rehbein H, Weirich TE, Westenfeld R, Brandenburg VM, Eitner F, Mayer J, Floege J, Sandmann W, Ketteler M.

Ann Vasc Surg. 2010 Apr;24(3):408-14. doi: 10.1016/j.avsg.2009.11.006. Epub 2010 Feb 7.

PMID:
20144533
50.

Glomerular disease: sugars and immune complex formation in IgA nephropathy.

Barratt J, Eitner F.

Nat Rev Nephrol. 2009 Nov;5(11):612-4. doi: 10.1038/nrneph.2009.165.

PMID:
19855421

Supplemental Content

Loading ...
Support Center